1. Home
  2. IMMX vs GROV Comparison

IMMX vs GROV Comparison

Compare IMMX & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$5.85

Market Cap

300.9M

Sector

Health Care

ML Signal

HOLD

Logo Grove Collaborative Holdings Inc.

GROV

Grove Collaborative Holdings Inc.

HOLD

Current Price

$1.20

Market Cap

55.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMMX
GROV
Founded
2014
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
300.9M
55.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IMMX
GROV
Price
$5.85
$1.20
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$12.00
$1.60
AVG Volume (30 Days)
1.3M
50.6K
Earning Date
11-07-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$180,808,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$16.02
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.34
$1.02
52 Week High
$7.73
$1.95

Technical Indicators

Market Signals
Indicator
IMMX
GROV
Relative Strength Index (RSI) 58.22 40.61
Support Level $5.58 $1.22
Resistance Level $7.73 $1.35
Average True Range (ATR) 0.77 0.06
MACD -0.09 -0.01
Stochastic Oscillator 51.39 26.32

Price Performance

Historical Comparison
IMMX
GROV

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

Share on Social Networks: